Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Clinical trial NCT00253539 · COMPLETED

Trial details

NCT number: NCT00253539
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Hereditary Breast/Ovarian Cancer (brca1, brca2)

Start date: 2002-01-01
Primary completion: 2005-04-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.